Histogenics is a tissue regeneration company developing breakthrough treatments for long-lasting joint repair. Its cartilage regeneration products apply advanced cell biology, tissue engineering, and materials science in the repair of injured or diseased joints, to restore joint function and prevent degenerative disease.

Damaged knee cartilage causes pain, restricts activity and often leads to osteoarthritis when left untreated. Since the body does not naturally regrow cartilage, and current treatment options do not regrow normal, healthy cartilage tissue, patients need new treatment options to achieve long-term relief. Osteoarthritis often results in the need for a total knee replacement, an option that is not advisable for patients under 60 years of age, for whom the need for preventative treatment is the greatest.

Histogenics has developed technology and products to reverse or prevent cartilage damage, regenerating healthy hyaline cartilage tissue. NeoCart®, autologous engineered neocartilage grown outside the body using the patient’s own cells, has been developed for repair of full thickness cartilage lesions. The VeriCart™ auto-regenerative cartilage matrix is being developed to stimulate cartilage regeneration in a simple, one-step procedure. The goal: an active lifestyle that can last all life long.